SLC6A3 and Lewy body dementia: While DAT scans have been used as diagnostic biomarkers in some trials, this also has the potential to select more parkinsonian phenotypes of LBD, and DAT scans may be negative in autopsy confirmed DLB where there is little nigral neurodegeneration or brainstem involvement [11,123].